메뉴 건너뛰기




Volumn 29, Issue 3, 2015, Pages 647-659

Erratum: Mapping the HLA ligandome landscape of acute myeloid leukemia: A targeted approach toward peptide-based immunotherapy (Leukemia (2015) 29 (647-659)) DOI:10.1038/leu.2014.233);Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HLA ANTIGEN CLASS 1; PEPTIDE VACCINE; EPITOPE; HLA ANTIGEN CLASS 2; LIGAND; PEPTIDE; TUMOR PROTEIN;

EID: 84924352568     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2016.1     Document Type: Erratum
Times cited : (99)

References (55)
  • 1
    • 0742324477 scopus 로고    scopus 로고
    • Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
    • Mailander V, Scheibenbogen C, Thiel E, Letsch A, Blau IW, Keilholz U. Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia 2004; 18: 165-166.
    • (2004) Leukemia , vol.18 , pp. 165-166
    • Mailander, V.1    Scheibenbogen, C.2    Thiel, E.3    Letsch, A.4    Blau, I.W.5    Keilholz, U.6
  • 2
    • 67049156789 scopus 로고    scopus 로고
    • Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer
    • Feyerabend S, Stevanovic S, Gouttefangeas C, Wernet D, Hennenlotter J, Bedke J et al. Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer. Prostate 2009; 69: 917-927.
    • (2009) Prostate , vol.69 , pp. 917-927
    • Feyerabend, S.1    Stevanovic, S.2    Gouttefangeas, C.3    Wernet, D.4    Hennenlotter, J.5    Bedke, J.6
  • 3
    • 38949092908 scopus 로고    scopus 로고
    • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses
    • Schmitt M, Schmitt A, Rojewski MT, Chen J, Giannopoulos K, Fei F et al. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses. Blood 2008; 111: 1357-1365.
    • (2008) Blood , vol.111 , pp. 1357-1365
    • Schmitt, M.1    Schmitt, A.2    Rojewski, M.T.3    Chen, J.4    Giannopoulos, K.5    Fei, F.6
  • 4
    • 4644289323 scopus 로고    scopus 로고
    • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
    • Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 2004; 101: 13885-13890.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 13885-13890
    • Oka, Y.1    Tsuboi, A.2    Taguchi, T.3    Osaki, T.4    Kyo, T.5    Nakajima, H.6
  • 5
    • 38049188363 scopus 로고    scopus 로고
    • Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
    • Rezvani K, Yong AS, Mielke S, Savani BN, Musse L, Superata J et al. Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood 2008; 111: 236-242.
    • (2008) Blood , vol.111 , pp. 236-242
    • Rezvani, K.1    Yong, A.S.2    Mielke, S.3    Savani, B.N.4    Musse, L.5    Superata, J.6
  • 6
    • 84864662070 scopus 로고    scopus 로고
    • Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
    • Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012; 18: 1254-1261.
    • (2012) Nat Med , vol.18 , pp. 1254-1261
    • Walter, S.1    Weinschenk, T.2    Stenzl, A.3    Zdrojowy, R.4    Pluzanska, A.5    Szczylik, C.6
  • 7
    • 23644455476 scopus 로고    scopus 로고
    • Drug therapy for acute myeloid leukemia
    • Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005; 106: 1154-1163.
    • (2005) Blood , vol.106 , pp. 1154-1163
    • Tallman, M.S.1    Gilliland, D.G.2    Rowe, J.M.3
  • 9
    • 33751267902 scopus 로고    scopus 로고
    • Acute myeloid leukaemia
    • Estey E, Dohner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907.
    • (2006) Lancet , vol.368 , pp. 1894-1907
    • Estey, E.1    Dohner, H.2
  • 10
    • 35748977610 scopus 로고    scopus 로고
    • Progress in the treatment of acute myeloid leukemia
    • Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Progress in the treatment of acute myeloid leukemia. Cancer 2007; 110: 1900-1910.
    • (2007) Cancer , vol.110 , pp. 1900-1910
    • Ravandi, F.1    Burnett, A.K.2    Agura, E.D.3    Kantarjian, H.M.4
  • 11
    • 0018764352 scopus 로고
    • Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts
    • Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068-1073.
    • (1979) N Engl J Med , vol.300 , pp. 1068-1073
    • Weiden, P.L.1    Flournoy, N.2    Thomas, E.D.3    Prentice, R.4    Fefer, A.5    Buckner, C.D.6
  • 12
    • 79952815781 scopus 로고    scopus 로고
    • Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
    • Bleakley M, Riddell SR. Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia. Immunol Cell Biol 2011; 89: 396-407.
    • (2011) Immunol Cell Biol , vol.89 , pp. 396-407
    • Bleakley, M.1    Riddell, S.R.2
  • 13
    • 0036129764 scopus 로고    scopus 로고
    • Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon
    • Brouwer RE, van der Heiden P, Schreuder GM, Mulder A, Datema G, Anholts JD et al. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon. Hum Immunol 2002; 63: 200-210.
    • (2002) Hum Immunol , vol.63 , pp. 200-210
    • Brouwer, R.E.1    Van Der Heiden, P.2    Schreuder, G.M.3    Mulder, A.4    Datema, G.5    Anholts, J.D.6
  • 14
    • 0037356948 scopus 로고    scopus 로고
    • Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia
    • Vollmer M, Li L, Schmitt A, Greiner J, Reinhardt P, Ringhoffer M et al. Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia. Br J Haematol 2003; 120: 1000-1008.
    • (2003) Br J Haematol , vol.120 , pp. 1000-1008
    • Vollmer, M.1    Li, L.2    Schmitt, A.3    Greiner, J.4    Reinhardt, P.5    Ringhoffer, M.6
  • 15
    • 84867400336 scopus 로고    scopus 로고
    • Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia
    • Anguille S, Van Tendeloo VF, Berneman ZN. Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Leukemia 2012; 26: 2186-2196.
    • (2012) Leukemia , vol.26 , pp. 2186-2196
    • Anguille, S.1    Van Tendeloo, V.F.2    Berneman, Z.N.3
  • 16
    • 84899949862 scopus 로고    scopus 로고
    • Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues
    • Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI et al. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues. Leukemia 2014; 28: 1167-1170.
    • (2014) Leukemia , vol.28 , pp. 1167-1170
    • Goswami, M.1    Hensel, N.2    Smith, B.D.3    Prince, G.T.4    Qin, L.5    Levitsky, H.I.6
  • 17
  • 18
    • 84857401848 scopus 로고    scopus 로고
    • Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: Lessons from early clinical trials
    • Van Driessche A, Berneman ZN, Van Tendeloo VF. Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials. Oncologist 2012; 17: 250-259.
    • (2012) Oncologist , vol.17 , pp. 250-259
    • Van Driessche, A.1    Berneman, Z.N.2    Van Tendeloo, V.F.3
  • 19
    • 58249088449 scopus 로고    scopus 로고
    • Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-speci fic CTL epitope
    • Li Z, Oka Y, Tsuboi A, Fujiki F, Harada Y, Nakajima H et al. Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-speci fic CTL epitope. Microbiol Immunol 2008; 52: 551-558.
    • (2008) Microbiol Immunol , vol.52 , pp. 551-558
    • Li, Z.1    Oka, Y.2    Tsuboi, A.3    Fujiki, F.4    Harada, Y.5    Nakajima, H.6
  • 20
    • 78649304608 scopus 로고    scopus 로고
    • Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model
    • Ma Q, Wang C, Jones D, Quintanilla KE, Li D, Wang Y et al. Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model. Cytotherapy 2010; 12: 1056-1062.
    • (2010) Cytotherapy , vol.12 , pp. 1056-1062
    • Ma, Q.1    Wang, C.2    Jones, D.3    Quintanilla, K.E.4    Li, D.5    Wang, Y.6
  • 21
    • 77952952932 scopus 로고    scopus 로고
    • High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
    • Greiner J, Schmitt A, Giannopoulos K, Rojewski MT, Gotz M, Funk I et al. High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma. Haematologica 2010; 95: 1191-1197.
    • (2010) Haematologica , vol.95 , pp. 1191-1197
    • Greiner, J.1    Schmitt, A.2    Giannopoulos, K.3    Rojewski, M.T.4    Gotz, M.5    Funk, I.6
  • 22
    • 77956384935 scopus 로고    scopus 로고
    • Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
    • Van Tendeloo VF, Van de Velde A, Van Driessche A, Cools N, Anguille S, Ladell K et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci USA 2010; 107: 13824-13829.
    • (2010) Proc Natl Acad Sci USA , vol.107 , pp. 13824-13829
    • Van Tendeloo, V.F.1    Van De Velde, A.2    Van Driessche, A.3    Cools, N.4    Anguille, S.5    Ladell, K.6
  • 23
    • 29844437061 scopus 로고    scopus 로고
    • Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia
    • Qazilbash MH, Rios R, Lu SJ, Giralt S. Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia. Blood 2004; 104: 77A.
    • (2004) Blood , vol.104 , pp. 77A
    • Qazilbash, M.H.1    Rios, R.2    Lu, S.J.3    Giralt, S.4
  • 24
    • 51549118696 scopus 로고    scopus 로고
    • PR1 vaccine elicited immunological response after hematopoietic stem cell transplantation is associated with better clinical response and event-free survival
    • Qazilbash MH, Thall PF, Wang X, Rios RL, Lu S. PR1 vaccine elicited immunological response after hematopoietic stem cell transplantation is associated with better clinical response and event-free survival. Blood 2007; 110: 178A.
    • (2007) Blood , vol.110 , pp. 178A
    • Qazilbash, M.H.1    Thall, P.F.2    Wang, X.3    Rios, R.L.4    Lu, S.5
  • 26
    • 33846534321 scopus 로고    scopus 로고
    • Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface
    • Weinzierl AO, Lemmel C, Schoor O, Muller M, Kruger T, Wernet D et al. Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics 2007; 6: 102-113.
    • (2007) Mol Cell Proteomics , vol.6 , pp. 102-113
    • Weinzierl, A.O.1    Lemmel, C.2    Schoor, O.3    Muller, M.4    Kruger, T.5    Wernet, D.6
  • 28
    • 84883718340 scopus 로고    scopus 로고
    • Natural HLA class I ligands from glioblastoma: Extending the options for immunotherapy
    • Neidert MC, Schoor O, Trautwein C, Trautwein N, Christ L, Melms A et al. Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. J Neurooncol 2013; 111: 285-294.
    • (2013) J Neurooncol , vol.111 , pp. 285-294
    • Neidert, M.C.1    Schoor, O.2    Trautwein, C.3    Trautwein, N.4    Christ, L.5    Melms, A.6
  • 29
    • 0025855156 scopus 로고
    • Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
    • Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351: 290-296.
    • (1991) Nature , vol.351 , pp. 290-296
    • Falk, K.1    Rotzschke, O.2    Stevanovic, S.3    Jung, G.4    Rammensee, H.G.5
  • 30
    • 84879310264 scopus 로고    scopus 로고
    • Biochemical large-scale identification of MHC class I ligands
    • Kowalewski DJ, Stevanovic S. Biochemical large-scale identification of MHC class I ligands. Methods Mol Biol 2013; 960: 145-157.
    • (2013) Methods Mol Biol , vol.960 , pp. 145-157
    • Kowalewski, D.J.1    Stevanovic, S.2
  • 31
    • 35748972060 scopus 로고    scopus 로고
    • Semi-supervised learning for peptide identification from shotgun proteomics datasets
    • Kall L, Canterbury JD, Weston J, Noble WS, MacCoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 2007; 4: 923-925.
    • (2007) Nat Methods , vol.4 , pp. 923-925
    • Kall, L.1    Canterbury, J.D.2    Weston, J.3    Noble, W.S.4    MacCoss, M.J.5
  • 32
    • 84875888331 scopus 로고    scopus 로고
    • Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons
    • Sturm T, Leinders-Zufall T, Macek B, Walzer M, Jung S, Pommerl B et al. Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons. Nat Commun 2013; 4: 1616.
    • (2013) Nat Commun , vol.4 , pp. 1616
    • Sturm, T.1    Leinders-Zufall, T.2    Macek, B.3    Walzer, M.4    Jung, S.5    Pommerl, B.6
  • 33
    • 84860224443 scopus 로고    scopus 로고
    • Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients
    • Widenmeyer M, Griesemann H, Stevanovic S, Feyerabend S, Klein R, Attig S et al. Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. Int J Cancer 2012; 131: 140-149.
    • (2012) Int J Cancer , vol.131 , pp. 140-149
    • Widenmeyer, M.1    Griesemann, H.2    Stevanovic, S.3    Feyerabend, S.4    Klein, R.5    Attig, S.6
  • 34
    • 37349077911 scopus 로고    scopus 로고
    • The CIMT-monitoring panel: A two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
    • Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C et al. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother 2008; 57: 289-302.
    • (2008) Cancer Immunol Immunother , vol.57 , pp. 289-302
    • Britten, C.M.1    Gouttefangeas, C.2    Welters, M.J.3    Pawelec, G.4    Koch, S.5    Ottensmeier, C.6
  • 35
    • 84255197842 scopus 로고    scopus 로고
    • Cancer immunotherapy comes of age
    • Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011; 480: 480-489.
    • (2011) Nature , vol.480 , pp. 480-489
    • Mellman, I.1    Coukos, G.2    Dranoff, G.3
  • 36
    • 0035144395 scopus 로고    scopus 로고
    • HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse
    • Wetzler M, Baer MR, Stewart SJ, Donohue K, Ford L, Stewart CC et al. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia 2001; 15: 128-133.
    • (2001) Leukemia , vol.15 , pp. 128-133
    • Wetzler, M.1    Baer, M.R.2    Stewart, S.J.3    Donohue, K.4    Ford, L.5    Stewart, C.C.6
  • 37
    • 84878372012 scopus 로고    scopus 로고
    • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
    • Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059-2074.
    • (2013) N Engl J Med , vol.368 , pp. 2059-2074
    • Cancer Genome Atlas Research Network1
  • 38
  • 39
    • 69049089548 scopus 로고    scopus 로고
    • The prioritization of cancer antigens: A national cancer institute pilot project for the acceleration of translational research
    • Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009; 15: 5323-5337.
    • (2009) Clin Cancer Res , vol.15 , pp. 5323-5337
    • Cheever, M.A.1    Allison, J.P.2    Ferris, A.S.3    Finn, O.J.4    Hastings, B.M.5    Hecht, T.T.6
  • 40
    • 84880160266 scopus 로고    scopus 로고
    • An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide
    • Hardwick N, Buchan S, Ingram W, Khan G, Vittes G, Rice J et al. An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide. Cancer Immun 2013; 13: 16.
    • (2013) Cancer Immun , vol.13 , pp. 16
    • Hardwick, N.1    Buchan, S.2    Ingram, W.3    Khan, G.4    Vittes, G.5    Rice, J.6
  • 41
    • 33947596047 scopus 로고    scopus 로고
    • A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells
    • Graf C, Heidel F, Tenzer S, Radsak MP, Solem FK, Britten CM et al. A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells. Blood 2007; 109: 2985-2988.
    • (2007) Blood , vol.109 , pp. 2985-2988
    • Graf, C.1    Heidel, F.2    Tenzer, S.3    Radsak, M.P.4    Solem, F.K.5    Britten, C.M.6
  • 42
    • 68049137903 scopus 로고    scopus 로고
    • Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation
    • Beatty GL, Smith JS, Reshef R, Patel KP, Colligon TA, Vance BA et al. Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation. Clin Cancer Res 2009; 15: 4944-4953.
    • (2009) Clin Cancer Res , vol.15 , pp. 4944-4953
    • Beatty, G.L.1    Smith, J.S.2    Reshef, R.3    Patel, K.P.4    Colligon, T.A.5    Vance, B.A.6
  • 43
    • 59449103841 scopus 로고    scopus 로고
    • Aurora-A kinase: A novel target of cellular immunotherapy for leukemia
    • Ochi T, Fujiwara H, Suemori K, Azuma T, Yakushijin Y, Hato T et al. Aurora-A kinase: a novel target of cellular immunotherapy for leukemia. Blood 2009; 113: 66-74.
    • (2009) Blood , vol.113 , pp. 66-74
    • Ochi, T.1    Fujiwara, H.2    Suemori, K.3    Azuma, T.4    Yakushijin, Y.5    Hato, T.6
  • 44
    • 84862578742 scopus 로고    scopus 로고
    • Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
    • Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR et al. Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood 2012; 119: 5492-5501.
    • (2012) Blood , vol.119 , pp. 5492-5501
    • Ochsenreither, S.1    Majeti, R.2    Schmitt, T.3    Stirewalt, D.4    Keilholz, U.5    Loeb, K.R.6
  • 45
    • 84865180738 scopus 로고    scopus 로고
    • Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia
    • Greiner J, Ono Y, Hofmann S, Schmitt A, Mehring E, Gotz M et al. Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia. Blood 2012; 120: 1282-1289.
    • (2012) Blood , vol.120 , pp. 1282-1289
    • Greiner, J.1    Ono, Y.2    Hofmann, S.3    Schmitt, A.4    Mehring, E.5    Gotz, M.6
  • 47
    • 4644271443 scopus 로고    scopus 로고
    • CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
    • Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 2004; 5: 927-933.
    • (2004) Nat Immunol , vol.5 , pp. 927-933
    • Sun, J.C.1    Williams, M.A.2    Bevan, M.J.3
  • 50
    • 0033662405 scopus 로고    scopus 로고
    • CD4(+) T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells
    • Qin ZH, Blankenstein T. CD4(+) T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000; 12: 677-686.
    • (2000) Immunity , vol.12 , pp. 677-686
    • Qin, Z.H.1    Blankenstein, T.2
  • 51
    • 44449137591 scopus 로고    scopus 로고
    • TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis
    • Muller-Hermelink N, Braumuller H, Pichler B, Wieder T, Mailhammer R, Schaak K et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 2008; 13: 507-518.
    • (2008) Cancer Cell , vol.13 , pp. 507-518
    • Muller-Hermelink, N.1    Braumuller, H.2    Pichler, B.3    Wieder, T.4    Mailhammer, R.5    Schaak, K.6
  • 53
    • 84882989956 scopus 로고    scopus 로고
    • Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor
    • Tomita Y, Yuno A, Tsukamoto H, Senju S, Kuroda Y, Hirayama M et al. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor. Clin Cancer Res 2013; 19: 4508-4520.
    • (2013) Clin Cancer Res , vol.19 , pp. 4508-4520
    • Tomita, Y.1    Yuno, A.2    Tsukamoto, H.3    Senju, S.4    Kuroda, Y.5    Hirayama, M.6
  • 54
    • 84882999952 scopus 로고    scopus 로고
    • 'License to kill' reflects joint action of CD4 and CD8 T cells
    • Melief CJ. 'License to kill' reflects joint action of CD4 and CD8 T cells. Clin Cancer Res 2013; 19: 4295-4296.
    • (2013) Clin Cancer Res , vol.19 , pp. 4295-4296
    • Melief, C.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.